LINK:  https://bswhealth.webex.com/bswhealth/j.php?MTID=m88920ffe70167a5d61855c230b6b2dc2

OBJECTIVES: Upon completion of this activity, the participant should be able to:  Identify NCCN guidelines for treatment of gliomas and central nervous system metastatic disease, (2) Recognize common presenting signs and symptoms of central nervous system tumors.

FACULTY DISCLOSURE: Karen Fink, MD does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

PLANNERS DISCLOSURES:  Karen Fink, MD does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

For information please contact Rachel Waller at [email protected]

Session date: 
04/28/2021 - 7:00am to 8:00am CDT
Location: 
Texas Oncology-Baylor Charles A. Sammons Cancer Center
3401 Worth Street, Ste 400
Dallas, TX 75246
United States
  • 1.00 AMA PRA Category 1 Credit
    The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance
Please login or register for this course.